Jacqueline Velo
Dermatology · Palm Beach Gardens, FLNPI 1295432938
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 28.4% of the total. 2025 is the largest year on record at $1,674, 4.0 times the $423 reported in 2023.
Across 104 payments — averaging $30.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$902
- Galderma Laboratories, L.p.$482
- UCB, Inc.$313
- Arcutis Biotherapeutics, Inc.$275
- Incyte Corporation$259
- LNHC, Inc$136
- plus $803 from 14 others
What the payments were for
- Travel & lodging$261%
- Food & beverage$3,07297%
- Education$722%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $902 |
| Galderma Laboratories, L.p. | 11 | $482 |
| UCB, Inc. | 7 | $313 |
| Arcutis Biotherapeutics, Inc. | 8 | $275 |
| Incyte Corporation | 7 | $259 |
| LNHC, Inc | 1 | $136 |
| Organon | 2 | $128 |
| Boehringer Ingelheim | 4 | $110 |
| Dermavant Sciences, Inc. | 1 | $107 |
| Sun Pharmaceutical Industries Inc. | 2 | $88 |
| Lilly USA, LLC | 4 | $81 |
| Botanix SB Inc | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Kerecis Limited | 1 | $38 |
| Amgen | 2 | $37 |
| Novartis | 2 | $31 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Almirall LLC | 1 | $20 |
| Biofrontera Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,169 in reported general payments places this provider in the 55th percentile of 1,147 dermatology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 153 | $2,453 |
| Betamethasone Dipropionate | 30 | $1,134 |
| Mupirocin | 143 | $917 |
| Clobetasol Propionate | 26 | $904 |
| Metronidazole | 12 | $618 |
| Gentamicin Sulfate | 17 | $611 |
| Triamcinolone Acetonide | 54 | $349 |
| Ammonium Lactate | 14 | $239 |
| ValacyclovirValacyclovir Hcl | 20 | $238 |
| Doxycycline Hyclate | 16 | $136 |
| Hydrocortisone | 24 | $114 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Palm Beach Gardens
- Michael BorensteinPalm Beach Gardens$170K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.